Molecular Partners Reports Highlights and Financial Results for Full Year 2025

Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed ...

Zevra Therapeutics: Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

Q4 net revenue of $34.1 million, representing 31% growth quarter-over-quarter FY 2025 net revenue of $106.5 million- driven by growth in MIPLYFFA net revenue to $87.4 million 2025 EPS of $1.40 basic ...

FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.
Health

What Happens to Your Body When You Take Vitamin C and Vitamin D Together

Taking vitamin C and D together boosts your immune system and supports bone health. Both vitamins may enhance wound healing and prevent infections.
The Manila Times

Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today reported its financial results ...